Windlas Biotech Q1 Results
- BSE: 543329
- NSE: WINDLAS
- ISIN: INE0H5O01029
- Sector: Biotechnology & Drugs
BSE
1,131
3.45 (0.31%)
3.45 (0.31%)Volume5.19 K
Updated: Fri 11 Sep, 2026 | 12:24:24
NSE
1,132.503.10 (0.27%)
3.10 (0.27%)Volume41.26 K
Updated: Fri 11 Sep, 2026 | 13:40:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹248.10 Cr.(18.09%)
- Operating Profit₹19.47 Cr.(2.08%)
- Profit After Tax₹17.65 Cr.(-0.06%)
- Operating Margin7.85%(-13.56%)
Note: Comparison is on YoY basis
Quarterly - Windlas Biotech Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 228.63 | 221.21 | 3.35% | 160.48 | 19.69% |
| Depreciation/ Amortization | 7.21 | 8.00 | -9.91% | 6.21 | -3.25% |
| Operating Income | 19.47 | 17.29 | 12.65% | 14.67 | 2.08% |
| Net Income | 17.65 | 15.99 | 10.40% | 13.48 | -0.06% |
| Other Operating Expenses Total | 24.26 | 24.79 | -2.17% | 17.02 | 12.27% |
| Net Income Before Taxes | 22.94 | 20.16 | 13.76% | 18.31 | -1.38% |
| Total Revenue | 248.10 | 238.50 | 4.03% | 175.15 | 18.09% |
| Selling/ General/ Admin Expenses Total | 44.43 | 41.37 | 7.41% | 27.85 | 37.86% |
| Diluted Normalized EPS | 8.32 | 7.39 | 12.61% | 6.44 | -0.24% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.